Louise Causer is a medical epidemiologist and lecturer at The Kirby Institute. She has interest and experience across a number of international public health issues, primarily those with an infectious disease focus including HIV, sexually transmissible infections (STIs) and malaria.
Louise’s current work at The Kirby Institute focuses on evaluations of point-of-care (POC) diagnostics for STIs. Louise is a co-investigator on the NHMRC funded TTANGO (and TTANGO2) “Test, Treat and Go” trial – a large, multisite, randomised controlled trial to evaluate the impact, cost-effectiveness, feasibility and acceptability of a new molecular based point-of-care (POC) test for chlamydia and gonorrhoea in remote community across Australia.
Louise has a long standing interest and passion working and conducting research in the field of infectious diseases (including malaria, tuberculosis, HIV and other STIs). Her focus in recent years has been on STIs, including syphilis, chlamydia and gonorrhoea and the potential role and impact for POC tests in remote communities across Australia, PNG and other resource limited settings.
In order for POC tests to be considered for programmatic implementation they must demonstrate accuracy, reliability, acceptability and cost effectiveness in the required setting. Current and future collaborative work with colleagues in Australia and in the Asia Pacific region will evaluate new POC diagnostic platforms for STIs including syphilis, chlamydia, gonorrhoea and trichomonas and investigate the feasibility of their use at a programmatic level in a variety of settings.
Broad Research Areas
Global Health, Infectious Diseases, HIV, STIs, POC diagnostics, operational research, implementation science
MBBS, MScPH, DTM&H, PhD
Specific Research Keywords
STI diagnosis; Point-of-care testing; syphilis; chlamydia; gonorrhoea; Indigenous health; remote Australia